CASK and hepatocellular carcinoma: Besides, the Kaplan–Meier analysis (http://kmplot.com/analysis/) indicated that HCC patients with high-CASK expression demonstrated poor overall survival rate, and consistent result was observed in HCC patients treated with sorafenib (Figures 1F, G).